GlassScriptPhysician profile
Michael Gene Spain
NPI 1952357733
$2,958.64
in general payments reported to CMS, 2019-2025
22 companies · $1,192 in 2025
The $1,192 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $84.18 · 2021: $443 · 2022: $394 · 2023: $76.24 · 2024: $618 · 2025: $1,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,886.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $751.91 | 2022-2025 | Linq II, Micra |
| Boston Scientific Corporation | $361.31 | 2019-2025 | General - Therapies, Peripheral Rotalink Plus |
| Heartflow, INC. | $315.29 | 2024 | |
| Abbott Laboratories | $305.40 | 2021-2025 | Jot Dx |
| Inari Medical, INC. | $287.66 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $193.73 | 2020-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $121.81 | 2025 | |
| Kestra Medical Technology Services, INC. | $96.32 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $70.55 | 2021-2025 | |
| Amgen INC. | $62.00 | 2022 | |
| Angiodynamics, INC. | $53.01 | 2021 | |
| Silk Road Medical, INC. | $52.10 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $41.80 | 2024 | Rhythm Express |
| Pfizer INC. | $40.94 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.14 | 2024-2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $38.09 | 2021 | |
| Novo Nordisk INC | $32.99 | 2025 | Ozempic |
| Teleflex LLC | $25.27 | 2019 | |
| Philips North America LLC | $21.29 | 2025 | Mcot |
| Cardiva Medical, INC. | $18.22 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2025 | Jardiance |
| W. L. Gore & Associates, INC. | $13.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Spain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.